University of Dundee

Cell Signalling and Immunology

Short Code: 

First funding from the beLAB1407 scheme for cross School collaboration

The University of Dundee has received an award of funding to develop a new therapeutic approach for inflammatory disorders, including inflammatory bowel disease (IBD).

The award was made by beLAB1407, a partnership between four leading UK academic institutions and the pharmaceutical companies Evotec and Bristol Myers Squibb. The initiative aims to achieve pre-clinical proof of concept for novel therapeutic targets with the goal of developing new spinout companies or licensing opportunities. 

Science and Business Fellowship awarded to Alison McFarlane

Alison McFarlane, a final year PhD student in Dr Ignacio Moragas lab in the Division of Cell Signalling and Immunology has been awarded a 2 year Science and Business Fellowship at The Janssen Pharmaceutical Companies Of Johnson & Johnson in Leiden, Netherlands.  

The Science & Business Fellowship started in June 2022 and is aimed at developing business and leadership skills, in addition to expanding research experience. In this way participants can develop into the (scientific) leaders of the future.  

Chancellor’s Award for Jenny Woof

Professor Jenny Woof has been named as one of this year’s winners of the Chancellor’s Award for Outstanding Contributions to Teaching. 

Professor Woof commented “I am delighted and honoured to receive this award. I’m very aware that delivery of an excellent programme of teaching can only be achieved through strong teamwork, and I am very fortunate to work with colleagues across the Schools of Life Sciences and Medicine who are so committed to delivery of a first-rate student experience.” 

Dundee ranked top University for Biological Sciences in REF 2021

The results of the 2021 Research Excellence Framework (REF) were announced today. Dundee is the top-ranking University for Biological Sciences research, a position we have maintained since the last REF exercise in 2014. The REF2021 assessment has scored SLS as having a total of 71% of its activities being ‘world leading’ (4*) and 28% of its activities being ‘internationally excellent’ (3*).